Alkem Laboratories Ltd posts rise in Q1FY22 consolidated PAT to Rs. 468.12 crore

Alkem Laboratories Limited has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.2778.01 crores during the period ended June 30, 2021 as compared to Rs.2238.44 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.468.12 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.239.99 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.39.15 for the period ended June 30, 2021 as compared to Rs.20.07 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 2778.01 crs	₹ 2238.44 crs	24.1%
Net Profit	₹ 468.12 crs	₹ 239.99 crs	95.06%
EPS	₹ 39.15	₹ 20.07	95.07%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.2778.01 crores during the period ended June 30, 2021 as compared to Rs.2046.99 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.468.12 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.422.01 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.39.15 for the period ended June 30, 2021 as compared to Rs.35.30 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 2778.01 crs	₹ 2046.99 crs	35.71%
Net Profit	₹ 468.12 crs	₹ 422.01 crs	10.93%
EPS	₹ 39.15	₹ 35.30	10.91%

Shares of Alkem Laboratories Limited was last trading in BSE at Rs. 3410.5 as compared to the previous close of Rs. 3379.9. The total number of shares traded during the day was 7699 in over 1387 trades.

The stock hit an intraday high of Rs. 3470 and intraday low of 3385.3. The net turnover during the day was Rs. 26411274.

Source : Equity Bulls

Keywords